These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3300235)

  • 1. Drug therapy and quality of life in angina pectoris.
    Taylor SH
    Am Heart J; 1987 Jul; 114(1 Pt 2):234-40. PubMed ID: 3300235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of quality-of-life evaluations in patients with angina pectoris.
    Gandjour A; Lauterbach KW
    Pharmacoeconomics; 1999 Aug; 16(2):141-52. PubMed ID: 10539395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of cardiovascular side effects with anti-anginal drugs.
    Rousan TA; Mathew ST; Thadani U
    Expert Opin Drug Saf; 2016 Dec; 15(12):1609-1623. PubMed ID: 27659354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three quality of life instruments in stable angina pectoris: Seattle Angina Questionnaire, Short Form Health Survey (SF-36), and Quality of Life Index-Cardiac Version III.
    Dougherty CM; Dewhurst T; Nichol WP; Spertus J
    J Clin Epidemiol; 1998 Jul; 51(7):569-75. PubMed ID: 9674663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines and methods for clinical investigation of drugs for treatment of stable angina pectoris].
    Wink K
    Arzneimittelforschung; 2003; 53(12):864-8. PubMed ID: 14732968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life Substudy.
    Tendera M; Chassany O; Ferrari R; Ford I; Steg PG; Tardif JC; Fox K;
    Circ Cardiovasc Qual Outcomes; 2016 Jan; 9(1):31-8. PubMed ID: 26696613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A; de Silva R
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery disease.
    Bonetti PO; Kaiser C; Zellweger MJ; Grize L; Erne P; Schoenenberger RA; Pfisterer ME;
    J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):29-37. PubMed ID: 15821836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic approach to refractory angina.
    Khan SN; Dutka DP
    Curr Opin Support Palliat Care; 2008 Dec; 2(4):247-51. PubMed ID: 19060562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of patients with stable angina pectoris on antianginal drug therapy.
    Hjemdahl P; Eriksson SV; Held C; Rehnqvist N
    Am J Cardiol; 1996 Jun; 77(16):6D-15D. PubMed ID: 8677897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of epanolol on quality of life.
    Jern S
    Drugs; 1989; 38 Suppl 2():71-4. PubMed ID: 2575987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Causes of Angina Pectoris in Survivors of Myocardial Infarction and the Role of Optimization of Antianginal Therapy. Data of the LINKOR Study E..].
    Glezer MG; Astashkin On Behalf Of The Linkor Study Investigators EI
    Kardiologiia; 2016 Dec; 56(11):5-11. PubMed ID: 28290813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial.
    Kardas P
    Vasc Health Risk Manag; 2007; 3(2):235-42. PubMed ID: 17580734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between exercise tolerance and quality of life in angina pectoris.
    Wiklund I; Comerford MB; Dimenäs E
    Clin Cardiol; 1991 Mar; 14(3):204-8. PubMed ID: 1672842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Angina Pectoris Associated with Coronary Microvascular Dysfunction.
    Ong P; Athanasiadis A; Sechtem U
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):351-356. PubMed ID: 27358172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS).
    Rehnqvist N; Hjemdahl P; Billing E; Björkander I; Eriksson SV; Forslund L; Held C; Näsman P; Wallén NH
    Eur Heart J; 1996 Jan; 17(1):76-81. PubMed ID: 8682134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of multiple-dose and once-daily nitrate therapy in 1212 patients with stable angina pectoris: effects on quality of life indices. Dutch Mononitrate Quality of Life (DUMQOL) Study Group.
    Niemeyer MG; Kleinjans HA; de Ree R; Zwinderman AH; Cleophas TJ; van der Wall EE
    Angiology; 1997 Oct; 48(10):855-62. PubMed ID: 9342964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in fibromyalgia and refractory angina pectoris: a comparison between two chronic non-malignant pain disorders.
    Andréll P; Schultz T; Mannerkorpi K; Nordeman L; Börjesson M; Mannheimer C
    J Rehabil Med; 2014 Apr; 46(4):341-7. PubMed ID: 24531267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Seattle angina questionnaire: reliability and validity in women with chronic stable angina.
    Kimble LP; Dunbar SB; Weintraub WS; McGuire DB; Fazio S; De AK; Strickland O
    Heart Dis; 2002; 4(4):206-11. PubMed ID: 12147179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angina in the elderly: the need for a balanced approach.
    Jackson G
    Int J Clin Pract; 2001 May; 55(4):231. PubMed ID: 11406906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.